Theme survey on technologies for lung or colorectal cancer launched by Swedish TLV

On October 31, 2022, the Dental and Pharmaceutical Benefits Agency (TLV) initiated conducting a theme survey for technologies used for the diagnosis or treatment of lung or colorectal cancer.

The purpose of the theme survey is to map the medical technology development in the field and to identify new medical technologies that may be important for healthcare in the next few years. This horizon scanning activity, commissioned by the Medical Technology Product (MTP) Council to TLV, is the first step of the national Orderly Introduction process for new medical technologies.

The manufacturers of medical devices have an opportunity to notify TLV about a new technology related to the theme of the survey. The notification form is available on the TLV website and should be submitted to registrator@tlv.se no later than November 22, 2022. The results of the theme survey will be compiled for the preparation group in December 2022, which will help further decision-making.

More details, as well as the notification form, can be found in Swedish here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.